Percutaneous cryoablation for the treatment of medically inoperable Stage I non-small cell lung cancer

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yamauchi, Yoshikane ^a   Izumi, Yotaro ^a   Hashimoto, Kohei ^a   Yashiro, Hideki ^a   Inoue, Masanori ^a   Nakatsuka, Seishi ^a   Goto, Taichiro ^a   Anraku, Masaki ^a   Ohtsuka, Takashi ^a   Kohno, Mitsutomo ^a   Kawamura, Masafumi ^b   Nomori, Hiroaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOABLATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMOPTYSIS; HISTOLOGY; HUMAN; INOPERABLE CANCER; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MALE; PLEURA EFFUSION; PNEUMOTHORAX; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUBE; VITAL CAPACITY; CRYOSURGERY; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CRYOSURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84857855632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033223     Document Type: Article

References (17)

1. Eradat J, Abtin F, Gutierrez A, Suh R, (2011) Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma. Cancer J 17: 38-48.
2. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, et al. (2010) Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery? International journal of radiation oncology, biology, physics.
3. Takeda A, Sanuki N, Kunieda E, Ohashi T, Oku Y, et al. (2009) Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. International journal of radiation oncology, biology, physics 73: 442-448.
4. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, et al. (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 2: S94-100.
5. Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, et al. (2009) Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery 137: 160-166.
6. Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, et al. (2007) Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. The Journal of thoracic and cardiovascular surgery 134: 857-864.
7. Kawamura M, Izumi Y, Tsukada N, Asakura K, Sugiura H, et al. (2006) Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. The Journal of thoracic and cardiovascular surgery 131: 1007-1013.
8. Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, et al. (2005) Thoracic Masses Treated with Percutaneous Cryotherapy: Initial Experience with More than 200 Procedures. Radiology 235: 289.
9. Yamauchi Y, Kawamura M, (2009) [Cryoablation for metastatic lung tumor derived from colorectal cancer]. Gan to kagaku ryoho Cancer & chemotherapy 36: 1259-1262.
10. Zemlyak A, Moore WH, Bilfinger TV, (2010) Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 211: 68-72.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
12. Fernando HC, De Hoyos A, Landreneau RJ, Gilbert S, Gooding WE, et al. (2005) Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. The Journal of thoracic and cardiovascular surgery 129: 639-644.
13. Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, et al. (2007) Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. The Journal of thoracic and cardiovascular surgery 134: 1306-1312.
14. Pennathur A, Abbas G, Schuchert MJ, Landreneau RJ, Luketich JD, (2010) Image-guided radiofrequency ablation for the treatment of early-stage non-small cell lung neoplasm in high-risk patients. Seminars in thoracic and cardiovascular surgery 22: 53-58.
15. Birim O, Kappetein AP, Bogers AJJC, (2005) Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 28: 759-762.
16. Birim O, Maat APWM, Kappetein AP, van Meerbeeck JP, Damhuis RAM, et al. (2003) Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery 23: 30-34.
17. Kunkle DA, Uzzo RG, (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113: 2671-2680.